Toronto, Ontario Feb 24, 2021 (Issuewire.com) - Microdose Psychedelic Insights (“Microdose”), a leader in B2B psychedelic intelligence, to present in a partnership with The Conscious Fund the most active VC in psychedelic space, the next edition of Psychedelic Capital.
#PsyCap is taking place on February 25h at 4:15 pm EST and will feature engaging presentations from MagicMed Industries, Algernon Pharmaceuticals Inc and Lobe Sciences.
Details and schedule of the February PsyCap are as follows:
4:15 pm EST: MagicMed Industries
Featuring Dr. Joseph Tucker.
"We are pleased to present at the upcoming Psychedelic Capital conference focused on psychedelic investment insights. Our team continues to advance the creation and patenting of psychedelics-derivatives for MagicMed’s molecular derivatives library, the Psybrary™️. We look forward to providing our current investor base and new potential shareholders with significant updates, including regarding our anticipated listing.” - Dr. Joseph Tucker.
4:45 pm EST: Algernon Pharmaceuticals Inc
Featuring Christopher Moreau, Cyndi Edwards, & David Nutt.
5:15 pm EST: Investment Banks
Featuring Michael Astone, Michael Huttner, & Henri Sant-Cassia.
5:45 pm EST: Lobe Sciences
Featuring Phil Young & Maghsoud Dariani.
6:15 pm: Retail Investors
Featuring Richard Skaife, Brandon Colwell, & Jeff Nielson.
Date:
February 25thth 2021 at 4:15 pm Eastern
Registration site:
https://microdose.buzz/shop/psychedelic-capital/psychedelic-capital-feb-2021/
Concept:
Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities, and deepest insights into the emerging psychedelic space. Live networking with all the attendees is available prior to and during the event.
- ENDS -
Notes to Editors
To request media accreditation, or to arrange interviews with key personnel please contact:
Kristina Spionjak
kristina@microdose.buzz
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy, and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and their intersection with healthcare, medicine, and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands, and an unrivalled network of scientists, researchers, analysts, innovators, investors, and advisors.
About PsyCap
This online event programming is dedicated to providing investment-grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders, and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities, and deepest insights into the emerging psychedelic space.
Media Contact
Microdose Psychedelic Insights *****@microdose.buzz https://microdose.buzz
